| Trial ID: | L0103 |
| Source ID: | NCT02365233
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Fatty Liver Study in Patients With Type II Diabetes
|
| Acronym: |
--
|
| Status: |
Terminated
|
| Study Results: |
Has Results
|
| Results: |
https://ClinicalTrials.gov/show/NCT02365233/results
|
| Conditions: |
Type II Diabetes|Nonalcoholic Fatty Liver
|
| Interventions: |
Drug: DPP4 inhibitor|Drug: Pioglitazone|Drug: Lantus insulin
|
| Outcome Measures: |
Change in Hepatic Lipid Content From Baseline Visit to Six Month Follow up Visit
|
| Sponsor/Collaborators: |
The University of Texas Medical Branch, Galveston
|
| Gender: |
All
|
| Age: |
18 Years and older ?? (Adult, Older Adult)
|
| Phases: |
Phase 4
|
| Enrollment: |
5
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
May 1, 2013
|
| Completion Date: |
December 31, 2016
|
| Results First Posted: |
July 31, 2018
|
| Last Update Posted: |
July 31, 2018
|
| Locations: |
University of Texas Medical Branch -Galveston, Galveston, Texas, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT02365233
|
